IDH1 Mutations in Gliomas: When an Enzyme Loses Its Grip

Slides:



Advertisements
Similar presentations
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Advertisements

Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Sirt4: The Glutamine Gatekeeper
Volume 1, Issue 4, Pages (December 2017)
Making Muscle or Mitochondria by Selective Splicing of PGC-1α
Melanocyte Stem Cell Maintenance and Hair Graying
Michael V. Berridge, Remy T. Schneider, Melanie J. McConnell 
ERRγ—A New Player in β Cell Maturation
Succinate: A New Epigenetic Hacker
Christopher J. Pirozzi, Zachary J. Reitman, Hai Yan  Cancer Cell 
HSF1 in Translation Cancer Cell
Mutant p53 gain of function: The NF-Y connection
Antagonizing ClpP: A New Power Play in Targeted Therapy for AML
Volume 9, Issue 2, Pages (August 2011)
A Mitochondrial Power Play in Lymphoma
Oncogenic B-Raf mutations
RAS’s Cloak of Invincibility Slips at Last?
A Sweet New Role for EGFR in Cancer
Telomeres and Cancer: From Crisis to Stability to Crisis to Stability
Mitochondrial ROS Fire Up T Cell Activation
SIRT6 Puts Cancer Metabolism in the Driver’s Seat
Volume 148, Issue 3, (February 2012)
You Down With ETC? Yeah, You Know D!
Muscle Fatigue from Losing Your PHD
Bringing IDH into the Fold
Hopping between Differentiation States in Lung Adenocarcinoma
Patrick S. Ward, Craig B. Thompson  Cancer Cell 
mTORC2 Puts Its Shoulder to Krebs’ Wheel
Volume 73, Issue 1, Pages 1-3 (January 2012)
Human Platelet Lipidomics: Variance, Visualization, Flux, and Fuel
Understanding the Intersections between Metabolism and Cancer Biology
Heike Döppler, Peter Storz  Cell Metabolism 
Christian M. Metallo, Matthew G. Vander Heiden  Molecular Cell 
Metabolomics and Metabolic Diseases: Where Do We Stand?
The great MYC escape in tumorigenesis
Cancer Cells Hijack Gluconeogenic Enzymes to Fuel Cell Growth
The Role of the RNAi Machinery in Heterochromatin Formation
Cancer Metabolism: Is Glutamine Sweeter than Glucose?
Mitochondria in the Regulation of Innate and Adaptive Immunity
The Ribosome Emerges from a Black Box
The Nurture of Tumors Can Drive Their Metabolic Phenotype
Volume 5, Issue 4, Pages (April 2007)
Lung Cancer Resets the Liver’s Metabolic Clock
Waste Not, Want Not: Lactate Oxidation Fuels the TCA Cycle
Mitochondria and Cancer
Wissam Assaily, Samuel Benchimol  Cancer Cell 
Pyruvate as a Pivot Point for Oncogene-Induced Senescence
Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells
Lindsay E. Wu, Ana P. Gomes, David A. Sinclair  Cancer Cell 
Volume 16, Issue 3, Pages (September 2009)
Muscle Fatigue from Losing Your PHD
Power Surge: Supporting Cells “Fuel” Cancer Cell Mitochondria
Linking Glycogen and Senescence in Cancer Cells
A Missing Link to Vitamin B12 Metabolism
Volume 35, Issue 6, Pages (December 2011)
Sirt4: The Glutamine Gatekeeper
Selfish Stem Cells Compete with Each Other
Mutant BRAF Melanomas—Dependence and Resistance
Role reversal: Brain insulin and liver STAT3
The Mitochondrial Pyruvate Carrier: Has It Been Unearthed at Last?
Nrf2 Orchestrates Fuel Partitioning for Cell Proliferation
Raffaele Teperino, Kristina Schoonjans, Johan Auwerx  Cell Metabolism 
Tracy-Ann Read, Robert J. Wechsler-Reya  Cancer Cell 
There's a Time and a Place for MYCN
Connecting with an Old Partner in a New Way
Ibrutinib Treatment of CLL: The Cancer Fights Back
New Myc-anisms for DNA Replication and Tumorigenesis?
On the Road to Bacterial Cell Death
The Role of TET2 in Hematologic Neoplasms
Presentation transcript:

IDH1 Mutations in Gliomas: When an Enzyme Loses Its Grip Christian Frezza, Daniel A. Tennant, Eyal Gottlieb  Cancer Cell  Volume 17, Issue 1, Pages 7-9 (January 2010) DOI: 10.1016/j.ccr.2009.12.031 Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 1 The Roles of IDH Enzymes in the Exchange of Metabolites between the Mitochondria and the Cytosol, and Their Potential Role in Tumorigenesis Many isoforms of TCA cycle enzymes (light blue) also operate in the cytosol. They are important for synchronizing bioenergetic and anabolic needs by directing TCA cycle metabolites and electrons, in the forms of NAD(P)H, in and out the mitochondria (red). The two major carbon sources for these metabolites are glucose and glutamine, which are catabolized via glycolysis (green) and glutaminolysis (purple), respectively. The three IDH isoenzymes are important players in these processes. IDH3 is part of the TCA cycle where it generates NADH as a fuel for energy production while IDH1 and 2 are important for shuttling electrons between the mitochondria and the cytosol. Although mutations in IDH1 are expected to hinder these processes, newly described work (Dang et al., 2009) proposes a new gain-of-function role for glioma-associated mutants of IDH1. R132 mutations of IDH1 generate a new enzyme with α-ketoglutarate reductase activity that produces 2-hydroxyglutarate and increased 2-hydroxyglutarate strongly correlates with cancer formation. But the tumorigenic mechanism is not yet understood. One possibility may be that 2-hydroxyglutarate inhibits PHD activity by competing with α-ketoglutarate binding. Solid or dashed lines indicate direct or indirect metabolic links, respectively. Cancer Cell 2010 17, 7-9DOI: (10.1016/j.ccr.2009.12.031) Copyright © 2010 Elsevier Inc. Terms and Conditions